|

Brezavvy 20Mg Oral Tablet Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Virginia1

Indications

  • Angina Patients With Non-obstructive Coronary Artery Disease1
  • Coronary Microvascular Disease1
  • Coronary Microvascular Dysfunction (CMD)1
  • Heart Disease1

Charlottesville, Virginia1 trial

Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)

UVA Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.